Cite
HARVARD Citation
Galand, C. et al. (n.d.). 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. Journal for immunotherapy of cancer. pp. A229-A230. [Online].